Letter: Safety and Efficacy Issues of Tirofiban Use in Endovascular Procedures: What Are the Actual Indications?

Neurosurgery. 2016 Jun;78(6):E895-6. doi: 10.1227/NEU.0000000000001233.

Authors

Daniele Bongetta¹, Cesare Zoia, Federica Melazzini, Elvis Lafe, Federico Zappoli Thyrion, Paolo Gaetani

Affiliation

¹ *Neurosurgery Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy ‡PhD Program in Experimental Medicine, Università degli Studi di Pavia, Pavia, Italy §Platelets Physiopathology Laboratory, Department of Internal Medicine ¶Interventional Neuroradiology Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.

PMID: 27035840
DOI: 10.1227/NEU.0000000000001233

No abstract available

Publication types

Letter
Comment

MeSH terms

Endovascular Procedures*
Humans
Myocardial Infarction
Platelet Aggregation Inhibitors
Tirofiban
Treatment Outcome
Tyrosine* / analogs & derivatives

Substances

Platelet Aggregation Inhibitors
Tyrosine
Tirofiban